iRhythm Technologies to Participate in Upcoming Investor Conferences in September
Rhea-AI Summary
iRhythm Technologies (NASDAQ:IRTC), a leading digital health care company, has announced its participation in three major investor conferences in September 2024. The company will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 at 3:20 pm ET, the Wells Fargo 2024 Healthcare Conference on September 5 at 8:45 am ET, and the Baird 2024 Global Healthcare Conference on September 10 at 2:00 pm ET.
Interested parties can access live and archived webcasts of these presentations through the "Events & Presentations" section of iRhythm's investor website at investors.irhythmtech.com. This series of conferences provides an opportunity for iRhythm to showcase its trusted solutions for disease detection, prediction, and prevention to the investment community.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, IRTC declined 1.17%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will present at the following investor conferences in September:
- Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, at 3:20 pm Eastern Time
- Wells Fargo 2024 Healthcare Conference on Thursday, September 5, at 8:45 am Eastern Time
- Baird 2024 Global Healthcare Conference on Tuesday, September 10, at 2:00 pm Eastern time
Those interested in listening to the presentations may do so by accessing the live and archived webcast of the events on the “Events & Presentations” section of the company’s investor website at investors.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com
Media Contact
Kassandra Perry
irhythm@highwirepr.com